Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Vertex VERX in the last three months. The table below provides a snapshot of their recent ...
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Vertex (NASDAQ:VERX) in the last three months. The table below provides a snapshot of their ...
If it wasn't obvious before, Latigo Biotherapeutics is all in on its non-opioid pain treatment pipeline and that is highlighted further by the company's $150 million Series B capital raise. Announced ...
Stands for Relative Strength Index. It is a momentum indicator used to identify overbought or oversold condition in the stock.Time period generally considered is 14 days. RSI reading below 25 is ...
Below is a table showing the current thinking of the analysts that cover Vertex Pharmaceuticals, Inc.: ...
In the latest quarter, 8 analysts provided ratings for Vertex VERX, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...
Now with Visual Q&A and Gemini 2.0, the search technology has even greater capabilities: Visual Q&A enables Vertex AI Search for healthcare to receive images such as tables, charts, or diagrams di ...
Pilgrim has raised INR 200 Cr in funding via a mix of primary and secondary transactions at a pre-money valuation of INR ...
Beauty and personal care product startup Pilgrim has raised Rs 200 crore (approximately $23 million) in a mix of primary and ...
We are the Artful Dodgers of the globalised world, experts at ducking and diving - but even the Dodger gets caught in the end ...
The following table shows Vertex’s direct customers, as well as indirect small business customers sold and serviced through the company’s one-to-many channel strategy. In addition to our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results